Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT01696994
What this trial is testing

Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

Who this might be right for
Ovarian CarcinomaOvarian Germ Cell Tumor
National Cancer Institute (NCI) 78,216
Testing effectiveness (Phase 2)UnknownNCT04504110
What this trial is testing

68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings

Who this might be right for
Epithelial Ovarian Cancer
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03026062
What this trial is testing

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Ended earlyNCT02978222
What this trial is testing

Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

Who this might be right for
Platinum Sensitive Ovarian CancerOvarian Cancer
Marker Therapeutics, Inc. 120
Not applicableLooking for participantsNCT06232122
What this trial is testing

Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chang Gung Memorial Hospital 45
Not applicableLooking for participantsNCT06295965
What this trial is testing

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+7 more
University of Washington 2,000
Not applicableStudy completedNCT03889171
What this trial is testing

Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests

Who this might be right for
CancerColorectal CancerBreast Cancer+1 more
University Hospital, Montpellier 200
Not applicableApproved For MarketingNCT03025867
What this trial is testing

Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Tesaro, Inc.
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT05952453
What this trial is testing

Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro

Who this might be right for
Ovarian Cancer
University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)UnknownNCT03393507
What this trial is testing

Apatinib Treatment in for Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerChemotherapeutic Toxicity
The People's Hospital of Leshan 34
Not applicableStudy completedNCT02493972
What this trial is testing

Interest of the Manual Exploration as a Supplement to the Coelioscopy in the Evaluation of the Resectability of Peritoneal Carcinosis

Who this might be right for
Ovarian Cancer With Peritoneal Carcinosis
Centre Francois Baclesse 40
Not applicableWithdrawnNCT01445275
What this trial is testing

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Who this might be right for
Fallopian Tube CarcinomaHereditary Breast and Ovarian Cancer SyndromeOvarian Carcinoma+1 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00653328
What this trial is testing

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Vanderbilt-Ingram Cancer Center 15
Not applicableStudy completedNCT00058032
What this trial is testing

CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women

Who this might be right for
Ovarian Cancer
University College, London 202,638
Testing effectiveness (Phase 2)Looking for participantsNCT07033819
What this trial is testing

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Who this might be right for
Ovarian Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 48
Testing effectiveness (Phase 2)UnknownNCT04720807
What this trial is testing

Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT00352300
What this trial is testing

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

Who this might be right for
Fallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more
Gynecologic Oncology Group 43
Next Page